Using Genomic Analysis to Guide Individual Treatment in Glioblastoma

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

March 12, 2015

Primary Completion Date

July 7, 2017

Study Completion Date

July 7, 2017

Conditions
Glioblastoma
Interventions
OTHER

Observational study, no intervention

Observational study, no intervention

Trial Locations (7)

10016

New York University Langone Medical Center, New York

10017

Memorial Sloan Kettering Cancer Center, New York

10065

Rockefeller University, New York

Weill Cornell Medical College, New York

10075

Lenox Hill Hospital, New York

10467

Montefiore Medical Center, The Bronx

11030

North Shore University Hospital, New York

All Listed Sponsors
collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

Lenox Hill Hospital

OTHER

collaborator

North Shore University Hospital

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Albert Einstein College of Medicine

OTHER

collaborator

New York Genome Center

OTHER

lead

Rockefeller University

OTHER

NCT02725684 - Using Genomic Analysis to Guide Individual Treatment in Glioblastoma | Biotech Hunter | Biotech Hunter